|
"orlando m"的相關文件
顯示項目 21-29 / 29 (共3頁)
<< < 1 2 3
每頁顯示[10|25|50]項目
| 亞洲大學 |
2018-01 |
Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer.
|
Chung, H.C.;Chung, H.C.;郭集慶;Kok, Victor C.;Chen, Rebecca;Cheng, Rebecca;Hsu, Y.;Hsu, Y.;Orlando, M.;Orlando, M.;Fuchs, C.;Fuchs, C.;Cho, J.Y.;Cho, J.Y.;* |
| 國立成功大學 |
2018 |
Ramucirumab safety in East Asian patients: A meta-analysis of six global, randomized, double-blind, placebo-controlled, phase III clinical trials
|
Yen, C.-J.;Muro, K.;Kim, T.-W.;Kudo, M.;Shih, J.-Y.;Lee, K.-W.;Chao, Y.;Kim, S.-W.;Yamazaki, K.;Sohn, J.;Cheng, R.;Zhang, Y.;Binder, P.;Mi, G.;Orlando, M.;Chung, H.C. |
| 國立成功大學 |
2018 |
Exposure–response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer
|
Kim, T.Y.;Yen, C.-J.;Al-Batran, S.-E.;Ferry, D.;Gao, L.;Hsu, Y.;Cheng, R.;Orlando, M.;Ohtsu, A. |
| 國家衛生研究院 |
2017-10 |
Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic review
|
Chen, LT;Oh, DY;Ryu, MH;Yeh, KH;Yeo, W;Carlesi, R;Cheng, R;Kim, J;Orlando, M;Kang, YK |
| 國立成功大學 |
2016-06 |
Exposure-Response relationship of second-line ramucirumab in East Asian patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study
|
Kim, T. Y.;Yen, C. -J.;Al-Batran, S. -E.;Gao, L.;Ferry, D.;Hsu, Y.;Cheng, R.;Orlando, M.;Ohtsu, A. |
| 臺大學術典藏 |
2016 |
Meta-Analysis of First-Line Pemetrexed Plus Platinum Treatment in Compared to Other Platinum-Based Doublet Regimens in Elderly East Asian Patients With Advanced Nonsquamous Non?�Small-Cell Lung Cancer
|
Wu Y.-L.;Orlando M;Wang X;Zhang X.-Q;Zhang P.-H;Chih-Hsin Yang;Wang J;Zhou C.-C;Cheng Y;Lu S; Lu S; Cheng Y; Zhou C.-C; Wang J; Chih-Hsin CHIH-HSIN YANG; Zhang P.-H; Zhang X.-Q; Wang X; Orlando M; Wu Y.-L. |
| 國家衛生研究院 |
2015-07 |
Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review
|
Park, JO;Oh, DY;Hsu, C;Chen, JS;Chen, LT;Orlando, M;Kim, JS;Lim, HY |
| 臺大學術典藏 |
2015 |
Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review
|
Oh D.-Y.; Chiun Hsu; Chen J.-S.; Chen L.-T.; Orlando M.; Kim J.S.; Lim H.Y.; Park J.O.; Park J.O.;Oh D.-Y.;Chiun Hsu;Chen J.-S.;Chen L.-T.;Orlando M.;Kim J.S.;Lim H.Y. |
| 中國醫藥大學 |
2014-11 |
Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-LineTreatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Tria
|
(Lee DH);(Lee JS);(Wang J);夏德椿(Te-Chun Hsia);(Wang X);(Kim J);(Orlando M)* |
顯示項目 21-29 / 29 (共3頁)
<< < 1 2 3
每頁顯示[10|25|50]項目
|
